Tradestie Institutional Equity Comparison Engine

BOLD vs JNJ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

JNJ Overall Edge

JNJ Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Johnson & Johnson (JNJ) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus JNJ at 23.3x Forward P/E and 26.6% operating margin (+5.9% YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against JNJ sits in CONSOLIDATION (45th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner JNJ
BOLD N/M vs JNJ 23.3x Fwd P/E
Growth & Margin Winner JNJ
Op Margin 0.0% vs 26.6% ยท YoY +0.0% vs +5.9%
Momentum & Technical Winner JNJ
1Y +101.7% vs +33.6% ยท 52W Pos 62% vs 78%
Options & Structure Winner JNJ
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (45th %ile IV)
BOLD NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap $56.2M
1M Return -4.92%
1Y Return +101.74%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 25.0 Fund 50.0 Flow 50.0 Mom 60.0
JNJ NYSE
Johnson & Johnson
Pharmaceutical Preparations
$270.47
+1.25% 1D
Market Cap $643.1B
1M Return +1.07%
1Y Return +33.56%
Forward P/E 23.3x
Unified AI Score
57.8 / 100 HOLD
Tech 47.0 Fund 54.0 Flow 66.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BOLD +101.74% JNJ +33.56% Spread: +68.18 pp (BOLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BOLD TTM Op. Margin: 0.0% JNJ TTM Op. Margin: 26.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BOLD vs JNJ. Trailing 12-month operating profitability (BOLD 0.0% vs JNJ 26.6%) and valuation multiples (BOLD N/M vs JNJ 23.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BOLD (0) vs JNJ (10)
Institutional Metric BOLD JNJ Criterion Row Winner
Market Capitalization Scale $56.2M $643.1B Larger Scale JNJ
Trailing P/E Ratio Valuation N/M 40.5x Lower Multiple JNJ
Forward P/E Ratio Valuation N/M 23.3x Lower Multiple JNJ
Revenue Growth (YoY) Growth +0.0% +5.9% Higher Growth JNJ
Operating Margin (TTM) Profitability 0.0% 26.6% Higher Margin JNJ
Net Profit Margin Profitability 0.0% 16.2% Higher Margin JNJ
Return on Equity (ROE) Capital Efficiency -64.6% 20.0% Higher ROE JNJ
52-Week Range Position Momentum 62% ($1โ€“$3) 78% ($199โ€“$290) Stronger Trend JNJ
Beta / 30D Volatility Risk Regime -0.08ฮฒ ยท 28% Vol -0.04ฮฒ ยท 25% Vol Lower Realized Risk JNJ
Unified Institutional Score Composite Signal 36.8 / 100 (SELL) 57.8 / 100 (HOLD) Higher Composite JNJ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BOLD vs JNJ Buy Guide
BOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
JNJ CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 45th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live JNJ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BOLD nor JNJ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.